학술논문

CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
Document Type
Article
Source
Frontiers in Immunology; 2024, p1-18, 18p
Subject
NEWCASTLE disease virus
CERVICAL cancer
CD44 antigen
CHITOSAN
ONCOLYTIC virotherapy
CANCER cell differentiation
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)